The DPM1 gene gives your cells instructions for making a helper protein used to attach certain sugar groups to other proteins, which helps many proteins fold and work properly. This gene helps your body build and maintain tissues that rely on those proteins, especially in the brain, muscles, and nerves. If the DPM1 gene does not work well, it can cause a rare inherited condition that affects several body systems and may lead to developmental delay, low muscle tone, seizures, feeding difficulties, and movement problems.

What is a gene?

Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes carry the information needed to make proteins, the parts of cells that do much of the work. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.

Overview

DPM1

Gene function

What if the gene works

The DPM1 gene helps your cells add specific sugar molecules to proteins. This supports normal protein folding, transport, and function throughout the body.

Risk

What if the gene does not work

Variants in the DPM1 gene can cause a congenital disorder of glycosylation, often with developmental delay, low muscle tone, seizures, and vision problems. Milder or more severe variants may change when symptoms begin and how pronounced they are.

Treatment

What does that mean for your treatment

For pathogenic or loss-of-function variants in the DPM1 gene, no DPM1-specific treatment or drug-selection approach is currently established. Care is supportive and based on the person’s symptoms and complications, while targeted therapies for DPM1-related glycosylation conditions remain under study.

Conditions associated with DPM1

Dpm1-cdg

Gene function

What if the gene works

Inside your cells, the DPM1 gene helps make a sugar carrying molecule that many proteins need before they can work normally. This step happens in the endoplasmic reticulum, the cell area that prepares proteins. Understanding how the DPM1 gene works can make it easier to see how your cells prepare proteins for transport, attachment, and everyday tasks.

Sugar donor

The DPM1 gene provides the working part of an enzyme that makes dolichol phosphate mannose, a sugar carrying molecule. Cells use this molecule as a ready source of mannose, a sugar needed during protein building and finishing.

Protein finishing

Many proteins need small sugar groups added before they can fold and travel properly. DPM1 supports this glycosylation process (adding sugars) as proteins move through the endoplasmic reticulum.

Surface attachment

Cells also use the sugar made through DPM1 to build GPI anchors (small links that hold proteins on the cell surface). This helps some proteins stay in the right place so they can signal or interact with nearby cells.

What is a variant?

A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Variants in the DPM1 gene can lower or disrupt production of a working protein, so cells make less dolichol phosphate mannose, a sugar donor needed for protein glycosylation (adding sugar chains). This is how variants influence the DPM1 gene's function at the cellular level. Milder variants may leave some activity, while more severe variants can cause near-complete loss of activity, often linking to earlier onset and more pronounced DPM1-CDG features.

How variants are linked to conditions

Pathogenic variants in the DPM1 gene cause DPM1-congenital disorder of glycosylation, often shortened to DPM1-CDG. This rare inherited condition is associated with developmental delay, low muscle tone, seizures, and health problems affecting several parts of the body, although the pattern can vary between people. In practical terms, the DPM1 gene and related conditions mainly point to this single, well-established diagnosis rather than a small change in risk for a common disease.

A variant is not necessarily a diagnosis

Genetic variants are a usual part of human biology, and they are widespread across the general population. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a certain gene is enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

For DPM1, risk is mainly shaped by inheritance rather than lifestyle. A child is affected when they inherit a disease-causing DPM1 change from both parents, so risk is higher in families with known carriers or when parents are related by blood. There is not enough evidence to say that diet, exercise, or other daily habits change this genetic risk.

Inheritance of DPM1 variants

DPM1-related conditions are inherited in an autosomal recessive pattern. In practical terms, DPM1 gene inheritance usually means a child is affected only when they receive one disease-causing variant from each parent. Parents who each carry one DPM1 gene variant are typically unaffected carriers, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child with neither variant. This inheritance pattern applies equally to boys and girls.

What does my DPM1 result mean for my family?

For DPM1, the main family implication is usually for siblings and parents. This gene is linked to a rare inherited condition that is typically passed down in a recessive way, so parents of an affected child are often healthy carriers, and brothers or sisters may also be affected or be carriers. Other relatives may also carry the changed gene, especially on the same side of the family.


Genetic information


Genetic testing

How you find out about variants

To find out about DPM1 variants, DPM1 genetic testing usually analyzes a blood or saliva sample with DNA sequencing, often as part of a multigene panel or exome test. It can identify whether you carry a benign change or a disease-causing variant, and results are interpreted alongside symptoms and family history.

When should I consider getting a genetic test?

Genetic testing for the DPM1 gene may be considered if a child has signs of a rare inherited condition that affects growth and development, such as low muscle tone, seizures, developmental delay, or feeding problems. It can also help when there is a family history of a DPM1-related condition or a known DPM1 variant in the family.

A genetic result is only one part of your health story

Genetic results can provide useful insight, but how much they reveal depends on the condition and the kind of variant involved. Lifestyle, environment, age, and medical history, among other factors, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, so the same dose may have a stronger effect, a weaker effect, or a different chance of side effects. These differences are common and are one reason a treatment that helps one person may not work the same way for someone else. Medication response also depends on other factors, including age, liver and kidney function, other medicines, and overall health.

What is Pharmacogenetics?

Pharmacogenetics examines how genetic differences can shape a person’s response to medications. By looking at connections between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment choices. More detail on this topic is available in the LearnHub.


Drugs influenced by the DPM1 gene

There are 0 Drugs associated with DPM1
Currently no available information

When should I seek medical advice?

There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so questions about side effects, new symptoms, or how your medicines may affect you are best discussed with your doctor or pharmacist.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved